195 related articles for article (PubMed ID: 35313217)
1. Differential parathyroid and kidney Ca
van Megen WH; Tan RSG; Alexander RT; Dimke H
EBioMedicine; 2022 Apr; 78():103947. PubMed ID: 35313217
[TBL] [Abstract][Full Text] [Related]
2. New insights into renal calcium-sensing receptor activation.
Dimke H
Curr Opin Nephrol Hypertens; 2024 Jul; 33(4):433-440. PubMed ID: 38690798
[TBL] [Abstract][Full Text] [Related]
3. Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).
Dong B; Endo I; Ohnishi Y; Kondo T; Hasegawa T; Amizuka N; Kiyonari H; Shioi G; Abe M; Fukumoto S; Matsumoto T
J Bone Miner Res; 2015 Nov; 30(11):1980-93. PubMed ID: 25967373
[TBL] [Abstract][Full Text] [Related]
4. Novel Calcium-Sensing Receptor (CASR) Mutation in a Family with Autosomal Dominant Hypocalcemia Type 1 (ADH1): Genetic Study over Three Generations and Clinical Characteristics.
Zung A; Barash G; Banne E; Levine MA
Horm Res Paediatr; 2023; 96(5):473-482. PubMed ID: 36812896
[TBL] [Abstract][Full Text] [Related]
5. Autosomal Dominant Hypocalcemia Type 1: A Systematic Review.
Roszko KL; Stapleton Smith LM; Sridhar AV; Roberts MS; Hartley IR; Gafni RI; Collins MT; Fox JC; Nemeth EF
J Bone Miner Res; 2022 Oct; 37(10):1926-1935. PubMed ID: 35879818
[TBL] [Abstract][Full Text] [Related]
6. Novel calcium-sensing receptor cytoplasmic tail deletion mutation causing autosomal dominant hypocalcemia: molecular and clinical study.
Obermannova B; Sumnik Z; Dusatkova P; Cinek O; Grant M; Lebl J; Hendy GN
Eur J Endocrinol; 2016 Apr; 174(4):K1-K11. PubMed ID: 26764418
[TBL] [Abstract][Full Text] [Related]
7. The Calcilytic Agent NPS 2143 Rectifies Hypocalcemia in a Mouse Model With an Activating Calcium-Sensing Receptor (CaSR) Mutation: Relevance to Autosomal Dominant Hypocalcemia Type 1 (ADH1).
Hannan FM; Walls GV; Babinsky VN; Nesbit MA; Kallay E; Hough TA; Fraser WD; Cox RD; Hu J; Spiegel AM; Thakker RV
Endocrinology; 2015 Sep; 156(9):3114-21. PubMed ID: 26052899
[TBL] [Abstract][Full Text] [Related]
8. CASR gene activating mutations in two families with autosomal dominant hypocalcemia.
Guarnieri V; Valentina D'Elia A; Baorda F; Pazienza V; Benegiamo G; Stanziale P; Copetti M; Battista C; Grimaldi F; Damante G; Pellegrini F; D'Agruma L; Zelante L; Carella M; Scillitani A
Mol Genet Metab; 2012 Nov; 107(3):548-52. PubMed ID: 22789683
[TBL] [Abstract][Full Text] [Related]
9. Autosomal dominant hypocalcemia with a novel
Wu Y; Zhang C; Huang X; Cao L; Liu S; Zhong P
J Int Med Res; 2022 Jul; 50(7):3000605221110489. PubMed ID: 35818129
[TBL] [Abstract][Full Text] [Related]
10. Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia.
Kinoshita Y; Hori M; Taguchi M; Watanabe S; Fukumoto S
J Clin Endocrinol Metab; 2014 Feb; 99(2):E363-8. PubMed ID: 24297799
[TBL] [Abstract][Full Text] [Related]
11. Identification of p.Arg205Cys in CASR in an autosomal dominant hypocalcaemia type 1 pedigree: A case report.
Ji Y; Kang C; Chen J; Zhang L
Medicine (Baltimore); 2021 Jun; 100(25):e26443. PubMed ID: 34160437
[TBL] [Abstract][Full Text] [Related]
12. Activating Mutations of the G-protein Subunit α 11 Interdomain Interface Cause Autosomal Dominant Hypocalcemia Type 2.
Gorvin CM; Stokes VJ; Boon H; Cranston T; Glück AK; Bahl S; Homfray T; Aung T; Shine B; Lines KE; Hannan FM; Thakker RV
J Clin Endocrinol Metab; 2020 Mar; 105(3):952-63. PubMed ID: 31820785
[TBL] [Abstract][Full Text] [Related]
13. Calcilytic NPSP795 Increases Plasma Calcium and PTH in an Autosomal Dominant Hypocalcemia Type 1 Mouse Model.
Hannan FM; Gorvin CM; Babinsky VN; Olesen MK; Stewart M; Wells S; Cox RD; Nemeth EF; Thakker RV
JBMR Plus; 2020 Oct; 4(10):e10402. PubMed ID: 33103030
[TBL] [Abstract][Full Text] [Related]
14. A calcium-sensing receptor mutation causing hypocalcemia disrupts a transmembrane salt bridge to activate β-arrestin-biased signaling.
Gorvin CM; Babinsky VN; Malinauskas T; Nissen PH; Schou AJ; Hanyaloglu AC; Siebold C; Jones EY; Hannan FM; Thakker RV
Sci Signal; 2018 Feb; 11(518):. PubMed ID: 29463778
[TBL] [Abstract][Full Text] [Related]
15. Autosomal dominant hypercalciuric hypocalcaemia: the calcium-sensing receptor in renal calcium homeostasis and the impact of renal transplantation.
Florance JA; Schollum JBW; Pomeranc A; Endre ZH; Walker RJ
Intern Med J; 2024 Jun; 54(6):852-860. PubMed ID: 38665051
[TBL] [Abstract][Full Text] [Related]
16. Autosomal dominant hypocalcemia due to a truncation in the C-tail of the calcium-sensing receptor.
Maruca K; Brambilla I; Mingione A; Bassi L; Capelli S; Brasacchio C; Soldati L; Cisternino M; Mora S
Mol Cell Endocrinol; 2017 Jan; 439():187-193. PubMed ID: 27561204
[TBL] [Abstract][Full Text] [Related]
17. Amino alcohol- (NPS-2143) and quinazolinone-derived calcilytics (ATF936 and AXT914) differentially mitigate excessive signalling of calcium-sensing receptor mutants causing Bartter syndrome Type 5 and autosomal dominant hypocalcemia.
Letz S; Haag C; Schulze E; Frank-Raue K; Raue F; Hofner B; Mayr B; Schöfl C
PLoS One; 2014; 9(12):e115178. PubMed ID: 25506941
[TBL] [Abstract][Full Text] [Related]
18. Identification of a G-Protein Subunit-α11 Gain-of-Function Mutation, Val340Met, in a Family With Autosomal Dominant Hypocalcemia Type 2 (ADH2).
Piret SE; Gorvin CM; Pagnamenta AT; Howles SA; Cranston T; Rust N; Nesbit MA; Glaser B; Taylor JC; Buchs AE; Hannan FM; Thakker RV
J Bone Miner Res; 2016 Jun; 31(6):1207-14. PubMed ID: 26818911
[TBL] [Abstract][Full Text] [Related]
19. Activating Calcium-Sensing Receptor Mutations: Prospects for Future Treatment with Calcilytics.
Mayr B; Glaudo M; Schöfl C
Trends Endocrinol Metab; 2016 Sep; 27(9):643-652. PubMed ID: 27339034
[TBL] [Abstract][Full Text] [Related]
20. [Calcium-sensing receptor and hypoparathyroidism].
Michigami T
Clin Calcium; 2007 Aug; 17(8):1186-91. PubMed ID: 17660614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]